True or central precocious puberty.
Kulin
H E
HE
Division of Pediatric Endocrinology, Pennsylvania State University College of Medicine, Hershey.
Bourguignon
J P
JP
D017373:Cyproterone Acetate / Q000627:therapeutic use; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use; D008297:Male; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D011629:Puberty, Precocious / Q000503:physiopathology / Q000628:therapy*; D013148:Spironolactone / Q000627:therapeutic use; D013738:Testolactone / Q000627:therapeutic use
D013148:Spironolactone; D007987:Gonadotropin-Releasing Hormone; D017373:Cyproterone Acetate; D013738:Testolactone; D017258:Medroxyprogesterone Acetate; D007654:Ketoconazole